E1	Procedure:T1 Name:T2 Temporality:E4
E5	Procedure:T5 Name:T6 Temporality:E8
E6	Age:T10 Numeric-Filter:E7
E7	Eq-Comparison:T17 Operator:T8 Value:T13 Temporal-Unit:T26
E8	Eq-Comparison:T18 Operator:T9 Value:T16 Temporal-Unit:T3
E9	Eq-Comparison:T19 Operator:T11 Value:T14 Value2:T15
E2	Condition:T20 Name:T21 Severity:T22
E4	Eq-Comparison:T23 Operator:T7 Operator2:T24 Value:T12 Temporal-Unit:T25
E10	Observation:T27 Name:T28 Numeric-Filter:E9
E11	Condition:T29 Name:T30
E12	Study:T31 Stability:T32
T1	Procedure 76 111	Immune checkpoint inhibitor therapy
T2	Procedure-Name 76 111	Immune checkpoint inhibitor therapy
T5	Procedure 240 275	Immune checkpoint inhibitor therapy
T6	Procedure-Name 240 275	Immune checkpoint inhibitor therapy
T7	Eq-Operator 122 128	within
T8	Eq-Operator 147 148	>
T9	Eq-Operator 286 287	>
T10	Age 143 146	Age
T11	Eq-Operator 163 164	-
T12	Eq-Value 133 134	2
T13	Eq-Value 148 150	18
T14	Eq-Value 162 163	0
T15	Eq-Value 164 165	3
T16	Eq-Value 288 289	2
T17	Eq-Comparison 147 151	>18y
T18	Eq-Comparison 286 292	> 2wks
T19	Eq-Comparison 162 165	0-3
T20	Condition 63 70	cancers
T21	Condition-Name 63 70	cancers
T22	Severity 54 62	Advanced
T23	Eq-Comparison 122 137	within +/- 2wks
T24	Eq-Operator 129 132	+/-
T25	Eq-Temporal-Unit 134 137	wks
T26	Eq-Temporal-Unit 150 151	y
T27	Observation 157 161	ECOG
T28	Observation-Name 157 161	ECOG
T3	Eq-Temporal-Unit 289 292	wks
T29	Condition 302 323	General vulnerability
T30	Condition-Name 302 323	General vulnerability
T31	Study 359 364	trial
T32	Stability 324 333	affecting
A1	Eq-Operator-Value T7 LTEQ
A2	Eq-Operator-Value T8 GT
A3	Eq-Operator-Value T9 GT
A4	Eq-Operator-Value T11 BETWEEN
A5	Severity-Value T22 severe
A6	Eq-Operator-Value T24 PLUS-MINUS
A7	Eq-Temporal-Unit-Value T25 week
A8	Eq-Temporal-Unit-Value T26 year
A9	Observation-Type-Value E10 measurement
A10	Eq-Temporal-Unit-Value T3 week
A12	Stability-Value T32 change
R1	Caused-By Arg1:T32 Arg2:E11